BioTech Medics, Inc. (BMCS)

BioTech Medics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2011	FY 2008
Period Ending	Sep 14, 2026	Dec 31, 2011	Dec 31, 2008
Market Capitalization	0	0	0
Market Cap Growth	-97.65%	-38.00%	-
Enterprise Value	-	0	0
Last Close Price	0.00	0.01	0.02

Price Ratios

Fiscal Year	Current	FY 2011	FY 2008
Period Ending	Sep 14, 2026	Dec 31, 2011	Dec 31, 2008
PS Ratio	0.09	0.03	0.05
PB Ratio	0.01	0.01	0.02
P/TBV Ratio	0.01	0.01	0.02

EV Ratios

Fiscal Year	Current	FY 2011	FY 2008
Period Ending	Sep 14, 2026	Dec 31, 2011	Dec 31, 2008
EV/Sales Ratio	-	0.01	0.01
EV/EBITDA Ratio	-	0.08	-

Financial Efficiency

Fiscal Year	Current	FY 2011	FY 2008
Period Ending	Sep 14, 2026	Dec 31, 2011	Dec 31, 2008
Debt / Equity Ratio	0.01	0.01	-
Debt / EBITDA Ratio	0.87	0.87	-
Net Debt / Equity Ratio	0.01	0.01	-0.01
Net Debt / EBITDA Ratio	0.79	0.79	-
Quick Ratio	0.00	0.00	0.02
Current Ratio	0.01	0.01	0.02
Return on Capital Employed (ROCE)	-19.10%	-19.10%	-2.70%

Yields

Fiscal Year	Current	FY 2011	FY 2008
Period Ending	Sep 14, 2026	Dec 31, 2011	Dec 31, 2008
Earnings Yield	-1491.74%	-3843.65%	-722.50%

Data Source: S&P Global Market Intelligence Last updated: Jul 5, 2012

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 16, 2026

Data Sources Report a data error